Q32 Bio Inc. (QTTB) stock
QTTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.53−0.10 (-1.16%)
Close on Nov 18, 2026Market cap $253.93MP/E –Yield –
Q32 Bio price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Q32 Bio's price to sales ratio was 304.8× on Oct 31, 2024, against 1.6× a year earlier. Over the last 5 years it ranged from 0.3× to 304.8×, with a median of 3.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Oct 31, 2024 | 304.8× | +304.3 |
| 2023 | Dec 29, 2023 | 0.4× | −2.0 |
| 2022 | Dec 30, 2022 | 2.4× | +1.8 |
| 2021 | Dec 31, 2021 | 0.7× | −23.6 |
| 2020 | Dec 31, 2020 | 24.2× | −18.7 |
| 2019 | Dec 31, 2019 | 42.9× | – |
See a number that looks wrong?